| Description | Lp-PLA2-IN-12 (compound 19), an Lp-PLA2 inhibitor, is utilized in researching neurodegenerative diseases including Alzheimer's disease (AD), glaucoma, age-related macular degeneration (AMD), and cardiovascular conditions such as atherosclerosis [1]. |
| molecular weight | 467.47 |
| Molecular formula | C24H23F2N5O3 |
| CAS | 2637485-14-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |